Peter Ove

2.0k total citations
54 papers, 1.7k citations indexed

About

Peter Ove is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Peter Ove has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Hepatology. Recurrent topics in Peter Ove's work include Drug Transport and Resistance Mechanisms (12 papers), DNA Repair Mechanisms (8 papers) and Liver physiology and pathology (8 papers). Peter Ove is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), DNA Repair Mechanisms (8 papers) and Liver physiology and pathology (8 papers). Peter Ove collaborates with scholars based in United States and Italy. Peter Ove's co-authors include Irving Lieberman, Richard Abrams, Mona L. Coetzee, Thomas E. Starzl, John László, A. Francavilla, Norma Hunt, Albert I. Lansing, Harold P. Morris and Lorenzo Polimeno and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Ove

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ove United States 24 894 277 240 238 199 54 1.7k
Henry S. Kingdon United States 26 770 0.9× 103 0.4× 176 0.7× 286 1.2× 94 0.5× 59 2.2k
Kinji Tsukada Japan 31 2.0k 2.2× 153 0.6× 131 0.5× 200 0.8× 137 0.7× 130 2.8k
Yannick Laperche France 26 680 0.8× 295 1.1× 285 1.2× 88 0.4× 330 1.7× 51 1.6k
Gerald L. Sattler United States 29 925 1.0× 752 2.7× 533 2.2× 376 1.6× 238 1.2× 44 2.2k
W. D. Kuhlmann Germany 20 417 0.5× 162 0.6× 253 1.1× 125 0.5× 144 0.7× 45 1.1k
Kojiro Matsumoto Japan 27 1.3k 1.4× 234 0.8× 129 0.5× 191 0.8× 448 2.3× 81 2.1k
Antonio Cantero Canada 21 829 0.9× 67 0.2× 165 0.7× 257 1.1× 132 0.7× 53 1.5k
Pierpaolo Coni Italy 21 605 0.7× 256 0.9× 167 0.7× 257 1.1× 199 1.0× 86 1.4k
Julius A. Goldbarg United States 13 592 0.7× 77 0.3× 178 0.7× 74 0.3× 301 1.5× 17 1.5k
Shuqi Mao China 23 544 0.6× 117 0.4× 379 1.6× 222 0.9× 147 0.7× 57 1.5k

Countries citing papers authored by Peter Ove

Since Specialization
Citations

This map shows the geographic impact of Peter Ove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ove more than expected).

Fields of papers citing papers by Peter Ove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ove. The network helps show where Peter Ove may publish in the future.

Co-authorship network of co-authors of Peter Ove

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ove. A scholar is included among the top collaborators of Peter Ove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ove. Peter Ove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makowka, L, et al.. (1989). Pharmacologic Modulation of Experimental Postischemic Hepatic Function. Annals of Surgery. 209(2). 200–210. 30 indexed citations
2.
Francavilla, A., Lorenzo Polimeno, Alfredo Di Leo, et al.. (1989). The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in Vitro. Hepatology. 9(4). 614–620. 104 indexed citations
3.
Ove, Peter, A. Francavilla, Mona L. Coetzee, L Makowka, & Thomas E. Starzl. (1989). Response of cultured hepatocytes to a hepatomitogen after initiation by conditioned medium or other factors.. PubMed. 49(1). 98–103. 5 indexed citations
4.
Makowka, L, et al.. (1988). Improved Hepatic Function in the 24-Hour Preserved Rat Liver With UW-Lactobionate Solution and SRI 63-441. Gastroenterology. 95(6). 1617–1624. 31 indexed citations
5.
Francavilla, A., et al.. (1986). Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy.. PubMed. 46(3). 1318–23. 69 indexed citations
6.
Lombardi, Benito, Peter Ove, & Tirumuru V. Reddy. (1985). Endogenous hepatic growth‐modulating factors and effects of a choline‐devoid diet and of phenobarbital on hepatocarcinogenesis in the rat. Nutrition and Cancer. 7(3). 145–154. 3 indexed citations
7.
Short, John, et al.. (1980). Involvement of the lodothyronines in liver and hepatoma cell proliferation in the rat.. PubMed. 40(7). 2417–22. 15 indexed citations
8.
Coetzee, Mona L., et al.. (1978). Selective response of DNA polymerase beta to bleomycin-induced breaks in DNA.. PubMed. 38(11 Pt 1). 3621–7. 17 indexed citations
9.
Coetzee, Mona L., et al.. (1975). Effect of a Normal Serum Protein Absent From Hepatoma-Bearing Animals on Cell Cultures 2. JNCI Journal of the National Cancer Institute. 54(1). 163–169. 3 indexed citations
10.
Coetzee, Mona L., et al.. (1975). DNA synthesis in membrane-denuded nuclei and nuclear fractions from host liver and Morris hepatomas.. PubMed. 35(10). 2752–61. 17 indexed citations
11.
Ove, Peter, Mona L. Coetzee, & Harold P. Morris. (1973). Separable DNA polymerase activities in host liver and Morris hepatomas.. PubMed. 33(6). 1272–83. 15 indexed citations
12.
Ove, Peter, et al.. (1972). Synthesis and degradation of liver proteins in young and old rats. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 277(1). 211–221. 60 indexed citations
13.
Ove, Peter, Oliver E. Brown, & John László. (1969). DNase II inhibitor in tissues and urine—pH and salt artifacts. Archives of Biochemistry and Biophysics. 131(2). 652–652. 5 indexed citations
14.
László, John, Peter Ove, William W. Shingleton, & Harold P. Morris. (1969). DNA Replication and Degradation in Mammalian Tissues. V. A Series of Slow-Growing Rat Renal Tumors and a Variety of Human Cancers<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 43(6). 1331–6. 5 indexed citations
15.
Ove, Peter & John László. (1969). Mammalian DNA Polymerase: Separation of Binding from Incorporation of Deoxyribonucleoside Triphosphates. Science. 165(3896). 903–904. 3 indexed citations
16.
Lieberman, Irving & Peter Ove. (1962). Deoxyribonucleic Acid Synthesis and Its Inhibition in Mammalian Cells Cultured from the Animal. Journal of Biological Chemistry. 237(5). 1634–1642. 72 indexed citations
17.
Lieberman, Irving & Peter Ove. (1960). Control of Growth of Mammalian Cells in Culture with Folic Acid, Thymidine, and Purines. Journal of Biological Chemistry. 235(4). 1119–1123. 19 indexed citations
18.
Lieberman, Irving & Peter Ove. (1960). Enzyme Studies with Mutant Mammalian Cells. Journal of Biological Chemistry. 235(6). 1765–1768. 51 indexed citations
19.
Lieberman, Irving & Peter Ove. (1958). CATALASE REQUIREMENT FOR MAMMALIAN CELLS IN CULTURE. The Journal of Experimental Medicine. 108(5). 631–637. 14 indexed citations
20.
Lieberman, Irving & Peter Ove. (1958). A Protein Growth Factor for Mammalian Cells in Culture. Journal of Biological Chemistry. 233(3). 637–642. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026